Cargando…
Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis
The standard therapy for primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA) which has shown to improve hepatic biochemistry, delay histological progression and improve transplant-free survival. Approximately 30–40% of patients do not respond or are intolerant to UDCA. Obeticholic acid,...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751712/ https://www.ncbi.nlm.nih.gov/pubmed/33364858 http://dx.doi.org/10.2147/JEP.S267375 |